In Silico Evaluation of the Antileukemia Activities of Thymoquinone by Targeting FLT3-ITD and BCR-ABL Signaling in Myeloid Leukemia. Trop J Nat Prod Res 2024, 8 (6), 7447-7451. https://doi.org/10.26538/tjnpr/v8i6.17.